InvestorsHub Logo

dr_c6

11/11/13 8:24 PM

#3956 RE: xoc #3955

If they can get the tests launched as LDTs and really enter the diagnostics and pharmaceutical testing market and get on NASDAQ, I think we are talking 25 - 30 dollars long term, or possible buyout target.
Arrayit is one to hold for long term growth.